Value Archives

Blog

Mastering Value Storytelling with Data-Driven Stories

Unlocking the Power of Storytelling in Healthcare Communication In the realm of healthcare communication, persuasion…

Certara2024年11月14日

Blog

Digital Payer Portals for Enhanced Value Communication

The trend of using digital tools for communication and information sharing in the life science…

Certara2024年8月9日

White Paper

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Since 2019, the Institute for Clinical and Economic Review (ICER) has published an annual Unsupported…

Danielle Pillsbury2023年7月25日

White Paper

新薬のマーケットアクセスを成功に導くためのリアルワールドエビデンスの利用

Jim Gallagher2021年9月29日

On-Demand Webinar

The Scary Future of Rare Disease Management

In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug…

Jim Gallagher2021年9月23日

Blog

バリューコミュニケーションの成功：新薬の紹介

Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…

Certara2021年8月5日

ビデオ

What is BaseCase?

Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…

Certara2021年7月20日

Blog

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence…

Certara2021年6月18日

On-Demand Webinar

Three Pathways have emerged in Innovative Access Agreements

The days of simply determining the market demand for a new drug as a function…

Jim Gallagher2021年6月11日

On-Demand Webinar

Outcomes Based Agreements

The days of simply determining the market demand for a new drug as a function…

Jim Gallagher2021年6月11日

バリュー

Mastering Value Storytelling with Data-Driven Stories

Digital Payer Portals for Enhanced Value Communication

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

新薬のマーケットアクセスを成功に導くためのリアルワールドエビデンスの利用

The Scary Future of Rare Disease Management

バリューコミュニケーションの成功：新薬の紹介

What is BaseCase?

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

Three Pathways have emerged in Innovative Access Agreements

Outcomes Based Agreements

メルマガ登録

クイックアクセス

ソリューション

お問合せ